Our Vision
The Alliance for Clinical Trials in Oncology seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer.
Our Mission
The mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by:
- Conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network
- Furthering our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice
- Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings
What We do
The Alliance for Clinical Trials in Oncology is a national leader in advancing cancer research, uniting over 25,000 cancer specialists at 115 main institutions and 1,400 affiliates across the U.S. and Canada. As part of the National Clinical Trials Network (NCTN) sponsored by the National Cancer Institute (NCI) and a leading research base for the NCI Community Oncology Research Program (NCORP), the Alliance conducts pioneering, practice-changing clinical trials that improve outcomes and reshape standards of care. Our work has led to multiple U.S. Food and Drug Administration (FDA) approvals, influenced national guidelines, and produced hundreds of high-impact publications. More than 40,000 participants have taken part in Alliance studies, and our growing biospecimen repository now includes over 1.5 million samples, collected over the past 30 years.
Learn more about collaborating with the Alliance here.
